Yanqing Li
17PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|Apr 24, 2025
Seven-Day Versus 14-Day Tegoprazan and Tetracycline-Containing Quadruple Therapy for First-Line Eradication of Helicobacter pylori Infection: A Randomized, Open-Label, Noninferiority Trial.Xue-Ping Nan, Hong-Yu Zhao, Lei-Na Guo
|Apr 16, 2025
Efficacy and Safety of Cefuroxime-Tetracycline-Containing Bismuth Quadruple Therapy for Helicobacter pylori Eradication in Penicillin-Allergic Patients: A Multicenter Randomized Controlled Trial.Hui Wang, Qingzhou Kong, Qiumei Zhang
|Aug 04, 2024
Artificial Intelligence-Generated Patient Education Materials for Helicobacter pylori Infection: A Comparative Analysis.Shuyan Zeng, Qingzhou Kong, Xiaoqi Wu
|Jul 30, 2024
Comparative analysis of large language models in medical counseling: A focus on Helicobacter pylori infection.Qing-Zhou Kong, Kun-Ping Ju, Meng Wan
|Jun 14, 2024
Efficacy of Tetracycline Three Times Daily was Comparable to That of Four Times Daily for Helicobacter pylori Rescue Treatment: A Multicenter, Noninferiority, Randomized Controlled Trial.Zhongxue Han, Qiumei Zhang, Iqtida Ahmed Mirza
|Jun 10, 2024
Fourteen-Day Tegoprazan-Amoxicillin Dual Therapy as the First-Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical Trial.Qingzhou Kong, Iqtida Ahmed Mirza, Xiaoqian Zhang
Pageof 3
